HER2/HER3 signaling was also reproducible in human prostate cancer cells treated with conditioned media (CM) from patient-derived prostate CAFs (PCAFs) that express endogenous ASPN, supporting a paracrine interaction model (Supplemental Figure 2, L–N). This evidence concerns the gene ERBB3 and prostate cancer.